サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451617

循環腫瘍細胞（CTC）市場レポート：技術、用途、製品、検体、エンドユーザー、地域別、2024-2032

Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 145 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
循環腫瘍細胞（CTC）市場レポート：技術、用途、製品、検体、エンドユーザー、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の循環腫瘍細胞（CTC）市場規模は2023年に118億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに261億米ドルに達し、2024年から2032年の間に8.9%の成長率（CAGR）を示すと予測しています。

循環腫瘍細胞（CTC）は、原発性腫瘍から分離し、単数またはクラスターとして循環系に出現するがん細胞です。CTCは、上皮性、間葉性、上皮性間葉性混合など異なる生物学的表現型を持っています。患者の血液中のCTCレベルは、がんの早期発見を可能にし、予後の指標として働く。CTCは微量であるため、免疫捕捉法、サイズベース分離法、密度ベース分離法、顕微鏡法など、いくつかの技術がCTCの分離、濃縮、検出に用いられています。CTCはまた、リキッドバイオプシー、がん研究、医薬品開発、臨床バイオマーカーなど幅広い用途に応用されています。

循環腫瘍細胞（CTC）市場動向：

遺伝的疾患によるがんの有病率の増加、アルコール消費量の増加、急速なライフスタイルの変化が市場成長を促進する主な要因です。CTCは、肺がん、乳がん、消化管がん、前立腺がんの早期発見とリアルタイムのモニタリングを支援します。これに伴い、転移の患者スクリーニングや新しい抗がん剤の前臨床試験におけるCTCの利用が増加しており、市場成長に好影響を与えています。さらに、低侵襲（MI）診断手技に対する需要の高まりと、迅速な回復を可能にし外傷を制限するためのCTCベースのリキッドバイオプシーの広範な採用が、市場成長にかなりの弾みをつけています。これとは別に、CTCの分離と検出の感度と効率を向上させるナノテクノロジーのイントロダクションが市場成長に弾みをつけています。さらに、薬物スクリーニング、疾患モデリング、ゲノム編集、腫瘍免疫のための細胞培養モデルを開発するための医学研究での利用が増加していることも、市場に明るい展望をもたらしています。さらに、早期がん診断の重要性に関するヘルスケア専門家や患者の意識の高まりが、市場成長にプラスの影響を与えています。その他の要因としては、バイオメディカルイメージングやバイオエンジニアリング技術の急速な進歩、広範な研究開発（R&D）活動、予防医療やコンパニオン診断の需要の高まりなどが挙げられ、市場成長の原動力になると予想されます。

本レポートで扱う主な質問

  • 2023年の世界の循環腫瘍細胞（CTC）市場規模は？
  • 2024～2032年の世界の循環腫瘍細胞（CTC）市場の予想成長率は？
  • 世界の循環腫瘍細胞（CTC）市場を牽引する主要因は何か？
  • COVID-19が世界の循環腫瘍細胞（CTC）市場に与えた影響は？
  • 技術別世界の循環腫瘍細胞（CTC）市場の内訳は？
  • 用途別世界の循環腫瘍細胞（CTC）市場の内訳は？
  • 製品別世界の循環腫瘍細胞（CTC）市場の内訳は？
  • 検体別世界の循環腫瘍細胞（CTC）市場の内訳は？
  • 世界の循環腫瘍細胞（CTC）市場の主要地域は？
  • 世界の循環腫瘍細胞（CTC）市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の循環腫瘍細胞（CTC）市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：技術別

  • CTC検出濃縮法
    • 市場動向
    • 市場予測
  • CTC直接検出法
    • 市場動向
    • 市場予測
  • CTC分析
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 臨床/リキッドバイオプシー
    • 市場動向
    • 主要セグメント
      • リスク評価
      • スクリーニングとモニタリング
    • 市場予測
  • 調査
    • 市場動向
    • 主要セグメント
      • がん幹細胞および腫瘍形成研究
      • 医薬品/治療開発
    • 市場予測

第8章 市場内訳：製品別

  • キット・試薬
    • 市場動向
    • 市場予測
  • 採血管
    • 市場動向
    • 市場予測
  • デバイスまたはシステム
    • 市場動向
    • 市場予測

第9章 市場内訳：検体別

  • 血液
    • 市場動向
    • 市場予測
  • 骨髄
    • 市場動向
    • 市場予測
  • その他の体液
    • 市場動向
    • 市場予測

第10章 市場内訳：エンドユーザー別

  • 病院・クリニック
    • 市場動向
    • 市場予測
  • 研究・学術機関
    • 市場動向
    • 市場予測
  • 診断センター
    • 市場動向
    • 市場予測

第11章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • BioFluidica Inc
    • Creatv MicroTech Inc.
    • CytoLumina Technologies Corp.
    • Fluxion Biosciences Inc.
    • Greiner Bio-One International GmbH
    • Ikonisys Inc
    • Menarini Silicon Biosystems
    • Miltenyi Biotec
    • Qiagen N.V
    • Rarecells Diagnostics
    • Stemcell Technologies
図表

List of Figures

  • Figure 1: Global: Circulating Tumor Cells Market: Major Drivers and Challenges
  • Figure 2: Global: Circulating Tumor Cells Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Circulating Tumor Cells Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Circulating Tumor Cells Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: Circulating Tumor Cells Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Circulating Tumor Cells Market: Breakup by Product (in %), 2023
  • Figure 7: Global: Circulating Tumor Cells Market: Breakup by Specimen (in %), 2023
  • Figure 8: Global: Circulating Tumor Cells Market: Breakup by End User (in %), 2023
  • Figure 9: Global: Circulating Tumor Cells Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Circulating Tumor Cells (CTC Detection and Enrichment Method) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Circulating Tumor Cells (CTC Detection and Enrichment Method) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Circulating Tumor Cells (CTC Direct Detection Methods) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Circulating Tumor Cells (CTC Direct Detection Methods) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Circulating Tumor Cells (CTC Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Circulating Tumor Cells (CTC Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Circulating Tumor Cells (Clinical/Liquid Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Circulating Tumor Cells (Clinical/Liquid Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Circulating Tumor Cells (Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Circulating Tumor Cells (Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Circulating Tumor Cells (Kits and Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Circulating Tumor Cells (Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Circulating Tumor Cells (Blood Collection Tubes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Circulating Tumor Cells (Blood Collection Tubes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Circulating Tumor Cells (Devices or Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Circulating Tumor Cells (Devices or Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Circulating Tumor Cells (Blood) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Circulating Tumor Cells (Blood) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Circulating Tumor Cells (Bone Marrow) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Circulating Tumor Cells (Bone Marrow) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Circulating Tumor Cells (Other Body Fluids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Circulating Tumor Cells (Other Body Fluids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Circulating Tumor Cells (Hospital and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Circulating Tumor Cells (Hospital and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Circulating Tumor Cells (Research and Academic Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Circulating Tumor Cells (Research and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Circulating Tumor Cells (Diagnostic Centres) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Circulating Tumor Cells (Diagnostic Centres) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: North America: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: North America: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: United States: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: United States: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Canada: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Canada: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Asia-Pacific: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Asia-Pacific: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: China: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: China: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Japan: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Japan: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: India: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: India: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: South Korea: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: South Korea: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Australia: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Australia: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Indonesia: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Indonesia: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Europe: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Europe: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Germany: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Germany: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: France: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: France: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: United Kingdom: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: United Kingdom: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Italy: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Italy: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Spain: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Spain: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Russia: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Russia: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Latin America: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Latin America: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Brazil: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Brazil: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Mexico: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Mexico: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Middle East and Africa: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Middle East and Africa: Circulating Tumor Cells Market: Breakup by Country (in %), 2023
  • Figure 86: Middle East and Africa: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Global: Circulating Tumor Cells Industry: SWOT Analysis
  • Figure 88: Global: Circulating Tumor Cells Industry: Value Chain Analysis
  • Figure 89: Global: Circulating Tumor Cells Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Circulating Tumor Cells Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Circulating Tumor Cells Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 3: Global: Circulating Tumor Cells Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Circulating Tumor Cells Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 5: Global: Circulating Tumor Cells Market Forecast: Breakup by Specimen (in Million US$), 2024-2032
  • Table 6: Global: Circulating Tumor Cells Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: Circulating Tumor Cells Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Circulating Tumor Cells Market: Competitive Structure
  • Table 9: Global: Circulating Tumor Cells Market: Key Players
目次
Product Code: SR112024A6316

The global circulating tumor cells (CTC) market size reached US$ 11.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 26.1 Billion by 2032, exhibiting a growth rate (CAGR) of 8.9% during 2024-2032.

Circulating tumor cells (CTC) are cancer cells that split away from the primary tumor and appear in the circulatory system as singular units or clusters. They have different biological phenotypes, such as epithelial, mesenchymal, and mixed epithelial-mesenchymal. CTC levels in a patient's blood can allow early detection of cancer and act as a prognostic indicator. As they are in minimal quantity, several technologies are used for the isolation, enrichment, and detection of CTC, such as immunocapture, size-based separation, density-based separation, and microscopy. It also has wide-ranging applications in liquid biopsy, cancer research, drug development, and clinical biomarkers.

Circulating Tumor Cells (CTC) Market Trends:

The increasing prevalence of cancer due to genetic disorders, rising alcohol consumption, and rapid lifestyle changes are key factors driving the market growth. CTC assists in the early identification and real-time monitoring of lung, breast, digestive tract, and prostate cancer. In line with this, the increasing utilization of CTC in patient screening for metastasis and preclinical studies of new cancer drugs is favoring the market growth. Furthermore, the growing demand for minimally invasive (MI) diagnostic procedures and widespread adoption of CTC-based liquid biopsy to enable rapid recovery and limit trauma are providing a considerable boost to the market growth. Apart from this, the introduction of nanotechnology to improve the sensitivity and efficiency of CTC isolation and detection is providing an impetus to market growth. Moreover, increasing utilization in medical research to develop cell culture models for drug screening, disease modeling, genome editing, and tumor immunity is creating a positive outlook for the market. Additionally, the increasing awareness amongst healthcare professionals and patients about the importance of early cancer diagnosis is positively influencing the market growth. Other factors, including rapid advancements in biomedical imaging and bioengineering technology, extensive research and development (R&D) activities, and the rising demand for preventive medicine and companion diagnostics, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global circulating tumor cells (CTC) market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on technology, application, product, specimen and end user.

Breakup by Technology:

CTC Detection and Enrichment Method

CTC Direct Detection Methods

CTC Analysis

Breakup by Application:

Clinical/Liquid Biopsy

Risk Assessment

Screening and Monitoring

Research

Cancer Stem Cell and Tumorigenesis Research

Drug/Therapy Development

Breakup by Product:

Kits and Reagents

Blood Collection Tubes

Devices and Systems

Breakup by Specimen:

Blood

Bone Marrow

Other Body Fluids

Breakup by End User:

Hospital and Clinics

Research and Academic Institutes

Diagnostic Centres

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being BioFluidica Inc, Creatv MicroTech Inc., CytoLumina Technologies Corp., Fluxion Biosciences Inc., Greiner Bio-One International GmbH, Ikonisys Inc, Menarini Silicon Biosystems, Miltenyi Biotec, Qiagen N.V, Rarecells Diagnostics and Stemcell Technologies.

Key Questions Answered in This Report

  • 1. What was the size of the global Circulating Tumor Cells (CTC) market in 2023?
  • 2. What is the expected growth rate of the global Circulating Tumor Cells (CTC) market during 2024-2032?
  • 3. What are the key factors driving the global Circulating Tumor Cells (CTC) market?
  • 4. What has been the impact of COVID-19 on the global Circulating Tumor Cells (CTC) market?
  • 5. What is the breakup of the global Circulating Tumor Cells (CTC) market based on the technology?
  • 6. What is the breakup of the global Circulating Tumor Cells (CTC) market based on the application?
  • 7. What is the breakup of the global Circulating Tumor Cells (CTC) market based on the product?
  • 8. What is the breakup of the global Circulating Tumor Cells (CTC) market based on the specimen?
  • 9. What are the key regions in the global Circulating Tumor Cells (CTC) market?
  • 10. Who are the key players/companies in the global Circulating Tumor Cells (CTC) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Circulating Tumor Cells (CTC) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 CTC Detection and Enrichment Method
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 CTC Direct Detection Methods
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 CTC Analysis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Clinical/Liquid Biopsy
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Risk Assessment
      • 7.1.2.2 Screening and Monitoring
    • 7.1.3 Market Forecast
  • 7.2 Research
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Cancer Stem Cell and Tumorigenesis Research
      • 7.2.2.2 Drug/Therapy Development
    • 7.2.3 Market Forecast

8 Market Breakup by Product

  • 8.1 Kits and Reagents
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Blood Collection Tubes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Devices or Systems
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Specimen

  • 9.1 Blood
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Bone Marrow
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Other Body Fluids
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospital and Clinics
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Research and Academic Institutes
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Diagnostic Centres
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 BioFluidica Inc
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Creatv MicroTech Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 CytoLumina Technologies Corp.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Fluxion Biosciences Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Greiner Bio-One International GmbH
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Ikonisys Inc
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Menarini Silicon Biosystems
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Miltenyi Biotec
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Qiagen N.V
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 Rarecells Diagnostics
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Stemcell Technologies
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio